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versus 2.1 ± 0.1, p = 0.05), and for the lesions with short stent length (18.6 ± 1.6 mm
versus 23.3 ± 1.4 mm, p = 0.04), with lipid-laden intima (88% versus 44%, p = 0.05),
thin-cap fibroatheroma (TCFA)-like intima (75% versus 31%, p = 0.04), and intimal
disruption (88% versus 27%, p < 0.01). A multiple logistic regression analysis
identified intimal disruption (odds ratio: 19.40, 95% confidence interval: 1.02 to
369.02; p = 0.049) as an independent risk factor for stent thrombosis. The lesions with
intimal disruption (n = 19) versus those without (n = 34) expressed a higher incidence
of ST (37% versus 3%, p = 0.002), lipid-laden intima (90% versus 29%, p < 0.0001),
and TCFA-like intima (84% versus 12%, p < 0.0001). Lesions with stent duration > 2
years (n = 30) versus the others (n = 23) raised the rates of cholesterol crystal (47%
versus 0%, p = 0.0001), calcified neointima (47% versus 4%, p = 0.0007), lipid-laden
intima (83% versus 9%, p < 0.0001), TCFA-like intima (60% versus 9%, p = 0.0001),
and intimal disruption (50% versus 17%, p = 0.01).
Conclusion: Long stent duration leads neointima to be atherosclerotic and disrupted
after bare-metal stenting. Late stent thrombosis might be associated with disrupted
neotissue.
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Background: We used virtual histology-intravascular ultrasound (VH-IVUS) to
evaluate the relation between coronary artery remodeling pattern and plaque
components in 1,133 patients.
Methods: We divided the patients into two groups according to the remodeling pattern
as positive remodeling (PR, remodeling index >1.05) (n=192) and intermediate
remodeling (IR, remodeling index ≤1.05 and >0.95)/negative remodeling (NR,
remodeling index <0.95) (n=941). VH-IVUS analysis classified the color-coded tissue
into four major components: green (fibrotic, FT); yellow-green (fibro-fatty); white
(dense calcium); and red (necrotic core, NC). Thin-cap fibroatheroma (TCFA) was
defined as focal, NC-rich (≥ 10% of the cross-sectional area) plaques being in contact
with the lumen in a plaque burden ≥ 40%.
Results: At the minimum lumen site, PR group had greater plaque plus media area
(12.8±4.9 vs. 9.9±3.8 mm2, p<0.001) and greater %NC area (21.7±12.3 vs.
18.2±11.6%, p<0.001) and smaller %FT area (57.0±14.5 vs. 59.4±14.6%, p=0.037)
compared with IR/NR group. PR group had greater plaque volume (188±150 vs.
135±130 mm3, p<0.001) and greater %NC volume (19.1±9.6 vs. 16.6±9.2%, p=0.001)
and smaller %FT volume (58.3±11.7 vs. 60.6±11.0%, p=0.009) compared with IR/NR
group. PR group had more TCFA compared with IR/NR group (21% vs. 13%,
p=0.006). Similar findings about plaque components were observed in terms of greater
%NC volume and smaller %FT volume in PR group compared with IR/NR group in
patients with both acute coronary syndrome and stable angina.
Conclusion: VH-IVUS analysis demonstrates that PR was associated with more
vulnerable plaque components compared with IR/NR regardless of their clinical
presentation.
TCT-102
Multiple Plaque Rupture, Erosion and Stability as Assessed by Optical
Coherence Tomography (OCT), Angioscopy, Intravascular Ultrasound (IVUS)
and Coronary Computed Tomographic Angiography (CT-angiography)
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Background: Atherosclerotic plaques associated with acute coronary syndromes
(ACS) on histopathological characterisation demonstrate either ruptured fibrous caps
(RFC) or intact fibrous caps (IFC). The latter IFC lesions are often referred to as plaque
erosions and are responsible for up to one-third of culprit lesions in ACS patients.
Invasive and non-invasive imaging modalities including OCT, angioscopy, IVUS and
CT-angiography would be useful to disclose the mechanism of ACS.
Methods: While 57 patients with ACS or stable angina consented to multiple invasive
and noninvasive imaging procedures, 63 culprit lesions were evaluated by CT-
angiography, OCT, angioscopy and IVUS. Whilst intraluminal thrombus was assessed
by OCT or angioscopy, culprit lesions were classified further by OCT-based
demonstration of fibrous-cap integrity.
Results: Of 38 culprit lesions with ACS, OCT revealed IFC with thrombus (erosion)
in 11 (29%) and ruptured fibrous cap in the remaining 27 (71%); all 25 lesions with
stable angina had intact-fibrous caps. Fibrous caps were significantly thinner in RFC-
ACS than IFC-ACS and stable angina by OCT (45±12μm, 146±49μm, 321±134μm,
respectively; p=0.001). CT verified that low-attenuation plaques were more frequently
observed in RFC-ACS than IFC-ACS and stable angina (85, 36, 16%; p=0.001) lesions.
Similarly, positive remodelling was more predominantly seen in RFC-ACS than IFC-
ACS and stable angina (93, 18, 12%; p=0.001). However, none of the specific
CT-angiography features clearly distinguished IFC-ACS from stable lesions.
Conclusion: IFC-ACS lesions based on OCT and angioscopic characteristics
demonstrated less low attenuation plaque and less positive remodelling than ruptured
plaques by CT-angiography. Since there are no unique CT features of non-ruptured
culprit lesions to enable their clear distinction from stable lesions, it will be difficult
to develop CT-based non-invasive imaging techniques to allow the clear identification
of subjects at high risk of developing ACS due to plaque erosion.
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Background: Drug-eluting stents (DES) decrease the risk of restenosis by reducing
the neointimal response. However, DES may impair strut coverage and this has been
associated with late stent/scaffold thrombosis (ST). Bioresorbable vascular scaffolds
(BVS) may overcome the risk of ST when completely resorbed. It is unknown if, during
the bioresorption process the neointimal response of the everolimus-BVS (Absorb)
differs from that of the metallic everolimus-DES (Xience). The objective of the present
study is to compare the neointimal response of Xience and Absorb assessed by optical
coherence tomography (OCT) at 1 year.
Methods: A total of 31 and 19 lesions were treated with a single Absorb or Xience
scaffolds and imaged with OCT at 1 year. Patients with ST elevation myocardial
infarction, chronic total occlusions or requiring overlapped stents were excluded.
Neointimal response was assessed as: percentage of uncovered struts, neointimal
thickness (NIT), in-stent/scaffold area obstruction and pattern of neointima.
Results: No significant differences in the angiographic lumen loss were seen for the
Xience and Absorb (0.18±0.20 mm vs. 0.29±0.36 mm; p=0.42). OCT analysis of 951
cross-sections and 8385 struts demonstrated similar rates of uncovered struts (5.3%
Xience vs. 4.5% Absorb; p=0.11), mean NIT (120.6±46.0 μm vs. 136.1±71.4 μm;
p=0.82) and in-stent/scaffold area obstruction (12.5±7.1% vs. 13.6±9.7%; p=0.91),
respectively. There was a trend of higher heterogenic tissue pattern of neointima (21.1%
vs. 6.5%; p=0.12) and less intra-luminal masses (0% vs. 12.9%; p=0.10) with Xience
than Absorb.
Conclusion: The Absorb everolimus-BVS demonstrated a similar neointimal response
as the Xience everolimus-DES; and the risk of scaffold thrombosis is, with that respect,
expected to be comparable to the Xience in the first year. However, the presence of
intra-luminal masses at 12 months in a small proportion of patients warranted watchful
follow-up of these cases.
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The Impact of Intravascular Ultrasound Guidance in Routine Percutaneous
Coronary Intervention for Conventional Lesions : Data from the EXCELLENT
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Background: Intravascular ultrasound (IVUS) offers tomographic images of coronary
artery, helping physicians refine percutaneous coronary intervention (PCI) procedures.
However, it is still controversial whether routine use of IVUS in conventional lesions
leads to improvement in clinical outcomes after PCI.
Methods: From the EXCELLENT trial, patients were grouped into IVUS-guided
versus IVUS-non-guided PCI (619 and 802 patients, respectively). The crude
population as well as the propensity score matched pairs were compared with regard
to clinical outcome. Thirty-two baseline clinical and angiographic variables were used
for propensity scoring.
Results: Baseline characteristics showed younger age and lower incidence of
comorbidities in the IVUS-guided PCI group. In 463 matched pairs (926 patients),
baseline characteristics were better comparable between the IVUS-guided versus non-
guided groups. In terms of procedure profiles, IVUS-guided PCI was associated with
longer stenting length, larger stent diameter, and greater number of stents implanted.
In the total population, IVUS guidance was associated with a significantly higher risk
of periprocedural MI. There were no significant differences in other outcomes. In the
matched cohort, IVUS guidance was associated with significantly increased risk of
target lesion failure at 1 year (4.3% vs. 2.4%; p=0.047 by conditional logistic
www.JACC.TCTAbstracts2011
B30 JACC Vol 58/20/Suppl B  |  November 7-11, 2011  |  TCT Abstracts/ORAL/Imaging
O
R
A
L
S
TUESDAY, NOVEMBER 8, 2011, 10:15 AM - 12:25 PM
regression) almost exclusively due to increased risk of periprocedural myocardial
infarction (MI) (1.6% vs. 0.2%; p=0.050), while the rates of cardiac death, spontaneous
MI, and target lesion revascluarization did not differ significantly between the two
groups.
Conclusion: The adjunctive use of IVUS during PCI in the EXCELLENT trial was
associated with more stents implanted, longer stenting, and bigger stenting. There were
no significant advantages of IVUS guidance regarding clinical outcome, but rather a
significant increase in periprocedural enzyme elevation, reflecting the more aggressive
procedures performed with IVUS guidance.
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Background: The impact of tissue prolapse (TP) on clinical outcomes after stent
implantation is still not well known. We used intravascular ultrasound (IVUS) to
evaluate the association of TP with short- and long-term clinical outcomes after stent
implantation in 418 acute myocardial infarction (AMI) patients (155 ST segment
elevation and 263 non-ST segment elevation MI).
Methods: TP was defined as tissue extrusion through the stent strut at post-stenting.
We evaluated the incidences of stent thrombosis, no-reflow, and long-term clinical
outcomes.
Results: After stenting, TP was detected in 34% without difference according to the
stent types. Acute and subacute stent thromboses occurred more frequently in patients
with TP compared with those without TP (3.5% vs. 0.7%, p=0.035, and 4.2% vs. 0.7%,
p=0.013, respectively). However, no significant difference was observed in the
incidence of late stent thrombosis between both groups. No-reflow was developed
more frequently in patients with TP compared with those without TP (25.4% vs. 9.8%,
p<0.001). Creatine kinase-MB and cardiac specific troponin-I were elevated more
significantly after stenting in patients with TP compared with those without TP
(+9.0±25.2 U/l vs. -4.2±41.6 U/l, p=0.001 and +10.0±43.5 ng/ml vs. -1.2±35.6 ng/ml,
p=0.005, respectively). There were no significant differences in the incidences of
cardiac death, MI, and target vessel revascularization at 1-year. Multivariate analysis
showed that TP was the independent predictor of composite of acute and subacute stent
thrombosis (OR=4.211; 95% CI 1.198-14.805, p=0.025) and composite of acute stent
thrombosis and no-reflow (OR=2.551; 95% CI 1.315-4.952, p=0.006).
Conclusion: TP was associated with short-term complications (acute and subacute
thrombosis and no-reflow phenomenon), however it was not affect long-term clinical
outcomes after stent implantation in patients with AMI.
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Background: Fully bioresorbable everolimus-eluting vascular scaffolds (ABSORB,
Abbott Vascular, Santa Clara, USA) are a novel approach to treat coronary stenosis.
However the outcome of jailed side branch with ABSORB has not been investigated
yet. The purpose of this study is to assess the fate of struts covering the ostium of side-
branches at 6, 12 and 24 months after implantation of the BVS with three-dimensional
(3-D) optical coherence tomography (OCT) reconstruction.
Methods: The ABSORB Cohort B trial is a single-arm trial to assess the safety and
performance of the BVS. The first 45 patients (Group 1) underwent invasive imaging
at 6 months and at 2 years, while the remained 56 patients (Group 2) underwent
imaging follow-up at 1 and will repeat it at 3 years. FD-OCT imaging (C7XR system)
are obtained at a pullback speed of 20 mm/s.
Results: Paired 3D images at baseline and 6 months were available in 16 side branches,
while paired analysis at baseline and 12-month follow-up were available in 17 side
branches. At 6 months, the average ostium area free from jailing struts did not change
from baselines (BL: 1.73 ± 1.35 mm2, FU: 1.64 ± 1.21 mm2, p=0.7), and the number
of compartments was similar between baseline and 6 months following implantation
(BL: 2.07±1.1, 6M: 1.93±1.0, p=0.16). At 12 months, 3D OCT showed that
membranous tissue covers some struts, which was translated into a significant decrease
in the number of compartments from 2.1 ± 0.8 at baseline to 1.4 ± 0.85 at 12 months
(p=0.001). This was accompanied by a decrease in the strut-free ostial area (BL: 1.89
± 1.35 vs. 12M: 0.76 ± 1.98 mm2) without clinical implication.
Conclusion: The 3-D analysis showed that the ostial area free of struts remained
unchanged at 6 months compared to baseline, while it was reduced at 12 months due
to growing tissue covering the struts. The results of 2-year imaging will be presented
at the time of meeting.
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Background: Pathologic studies suggest that calcified coronary nodules account for
2-7% of thrombotic events. The frequency, distribution, predictors, and outcomes of
calcified nodules detected in vivo have never been described.
Methods: Following successful stenting in 697 patients with acute coronary syndromes
(ACS), three-vessel grayscale and virtual histology (VH) intravascular ultrasound
(IVUS) was performed. Based on histologic validation, an independent core lab
identified calcified nodule as irregular and convex plaque shape. Patients were followed
for three years.
Results: Overall, 314 calcified nodules were detected in 250 of 1573 analyzable
arteries (185 of 623 patients). Thus, the prevalence of calcified nodules was 17% per
artery and 30% per patient. The location of the calcified nodules were <40mm of the
ostium of the coronary artery in 85% of LAD and 86% of LCX while calcified nodules
within the RCA were evenly and more distally distributed. Patients with calcified
nodules were significantly older, had more plaque volume (IVUS), and more thick-
capped fibroatheroma (VH-IVUS), but fewer non-culprit lesion major adverse events
on follow-up.
Table. Clinical Characteristics, imaging parameters and clinical event rates
comparing patients with vs without calcified nodules
DC = dense calcium; NC = necrotic core
Conclusion: Calcified nodules in untreated non-culprit coronary segments in patients
with ACS are more prevalent than previously recognized; their distribution mirrors the
origin of most thrombotic events. However, they are unlikely to cause events during
3-year follow-up.
TCT-108
Intraoperative Shuntography for Immediate Control and Improvement of
Results of Coronary Bypass Surgery
Bagrat Alekyan, Leo Bockeria, Narek Zakarian, Anton Staferov, Karen Petrosian,
Andrey Abrosimov
Bakoulev Scientific Center for Cardiovascular Surgery, Moscow, Russian Federation
Background: To analyze our experience with intraoperative shuntography for
immediate evaluation of coronary shunts condition in patients after CABG.
Methods: The study comprised 1084 patients who received 2707 coronary shunts
during the period from February 2009 through April 2011. The patients’ age varied
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